Q2 2026 Holdings
Filed 2026-08-14 | 147 holdings | $438.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco DB Commdy Indx Trck(DBC) | UNIT | 46138B103 | $28.2M | 1,057,238 | 6.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $15.1M | 113,031 | 3.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $12.5M | 66,983 | 2.9% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $11.4M | 242,884 | 2.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $10.7M | 277,873 | 2.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $10.1M | 30,210 | 2.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $9.5M | 506,235 | 2.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $9.4M | 179,256 | 2.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.7M | 149,739 | 2.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $8.1M | 260,070 | 1.9% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $7.8M | 97,896 | 1.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.3M | 188,780 | 1.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $7.0M | 130,784 | 1.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $7.0M | 137,866 | 1.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $6.9M | 386,080 | 1.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $6.9M | 77,807 | 1.6% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $6.9M | 211,511 | 1.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.6M | 78,003 | 1.5% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $6.3M | 1,348,136 | 1.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $5.9M | 184,774 | 1.3% |
| Alumis Inc(ALMS) | COM | 022307102 | $5.6M | 199,968 | 1.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $5.5M | 160,494 | 1.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $5.5M | 87,060 | 1.2% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.3M | 371,120 | 1.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $5.0M | 51,125 | 1.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $4.9M | 203,739 | 1.1% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $4.9M | 20,183 | 1.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.9M | 86,233 | 1.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $4.5M | 105,907 | 1.0% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $4.4M | 21,792 | 1.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $4.3M | 158,770 | 1.0% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $4.2M | 2,030,927 | 1.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.2M | 4,561 | 1.0% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $4.1M | 136,572 | 0.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $4.0M | 408,534 | 0.9% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $4.0M | 41,902 | 0.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.8M | 171,961 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.7M | 90,996 | 0.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.7M | 187,946 | 0.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.3M | 31,256 | 0.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.2M | 86,964 | 0.7% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $3.2M | 13,397 | 0.7% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.1M | 831,442 | 0.7% |
| Talen Energy Corp(TLN) | COM | 87422Q109 | $3.1M | 8,148 | 0.7% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $3.1M | 445,799 | 0.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.0M | 24,460 | 0.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $2.9M | 160,328 | 0.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.9M | 159,885 | 0.7% |
| Hewlett Packard Enterprise C(HPE) | COM | 42824C109 | $2.7M | 59,081 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $2.3M | 86,085 | 0.5% |